Arcosa, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Arcosa, Inc. (NYSE: ACA) provides infrastructure-related products and solutions through leading brands serving the construction, engineered structures, and transportation markets. The company operates in three primary segments: Construction Products, offering aggregates, specialty materials including lightweight aggregates, and construction site support; Engineered Structures, encompassing utility structures, pole products, telecom structures, traffic structures, and wind towers; and Transportation Products, including barges and marine hardware as well as industrial components. Arcosa manufactures and sells these products primarily to infrastructure, energy, residential, non-residential, agricultural, and transportation end markets across North America. Founded in 2018 through a spin-off from Trinity Industries, Inc., Arcosa maintains its headquarters in Dallas, Texas, and employs approximately 6,250 people. The company's businesses leverage strong geographic footprints in the United States to support infrastructure growth, population expansion, and the replacement of aging transportation and energy infrastructure. In recent developments, Arcosa completed the $1.2 billion acquisition of the construction materials business of Stavola Holding Corporation on October 1, 2024, significantly expanding its aggregates-led platform into high-growth markets and increasing Construction Products to nearly two-thirds of adjusted EBITDA. This transaction, funded partly through a $600 million senior note issuance, aligned with the company's strategy to grow in attractive markets, reduce cyclicality, and enhance returns on invested capital while divesting non-core assets like its steel components business. For 2025, Arcosa projects consolidated revenues of $2.8-3.0 billion and adjusted EBITDA of $545-595 million, driven by approximately 40% organic growth and contributions from the Stavola integration.
Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?
Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?
Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA
Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA
Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts
Ibstock (OTCMKTS:IBJHF) versus Arcosa (NYSE:ACA) Head to Head Comparison
Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?
Arcosa (ACA) Q2 Earnings and Revenues Lag Estimates
Here's What Key Metrics Tell Us About Arcosa (ACA) Q2 Earnings
Arcosa, Inc. Announces Second Quarter 2026 Results
Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders?
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN
Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders?
Arcosa, Inc. to Announce Second Quarter 2026 Results on August 5, 2026
Has Arcosa (ACA) Outpaced Other Construction Stocks This Year?
Do Options Traders Know Something About Arcosa Stock We Don't?
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)
Shareholder Alert: Ademi LLP investigates whether Arcosa, Inc. is obtaining a Fair Price for Public Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)